Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-016-0217-4
Published Online: 2016-12-19
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lorenzi, Maria
Ploug, Uffe Jon
Langer, Jakob
Skovgaard, Rasmus
Zoratti, Michael
Jansen, Jeroen
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2016-12-19
Article History
Received: 28 October 2016
First Online: 19 December 2016